Keywords: اینترلوکین-1; anakinra; hairy cell leukemia; interleukin-1 receptor antagonist; Schnitzler syndrome; urticaria; CRP; C-reactive protein; IL-1; interleukin-1;
مقالات ISI اینترلوکین-1 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: اینترلوکین-1; RA; rheumatoid arthritis; RF; rheumatoid factor; ACPA; anti-citrullinated protein antibodies; AA; arachidonic acid; PG; prostaglandins; LT; leukotrienes; TX; thromboxanes; LX; lipoxins; NSAID; non steroidal anti-inflammatory drugs; COXIB; COX-2 selective
Keywords: اینترلوکین-1; ADP; adenosine diphosphate; APC; activated protein C; AT-III; antithrombin III; ATP; adenosine triphosphate; cAMP; cyclic adenosine monophosphate; CLP; cecal ligation - perforation; DIC; disseminated intravascular coagulation; LPS; lipopolysaccharide; IL-
Keywords: اینترلوکین-1; ATG; autophagy-related proteins; CMA; chaperone-mediated autophagy; ULK1; Unc-51-like kinase 1; PI3K; phosphatidylinositol 3-kinase; mTOR; mammalian target of rapamycin; PE; phosphatidylethanolamine; IFN-γ; interferon-γ; IL-1; interleukin-1; IL-17; inte
Keywords: اینترلوکین-1; Autoinflammatory disorder; Inflammation; Interleukin-1; Child;
Keywords: اینترلوکین-1; Interleukin-1 receptor antagonist; Myocardium; Calcium overload; IP3 receptor; Ischaemia/reperfusion-induced injury; Antagoniste des récepteurs à l'interleukine I; Myocarde; Surcharge calcique; Récepteur IP3; Lésions ischémie/reperfusion myocardiqu
Keywords: اینترلوکین-1; Pattern-recognition receptors (PRRs); Toll-like receptors (TLRs); RIG-I-like receptors (RLRs); NOD-like receptors (NLRs); Small molecule modulators; BIR; baculovirus inhibitor repeat; CARD; caspase recruitment domains; CFS; chronic fatigue syndrome; CLR;
Keywords: اینترلوکین-1; autoinflammatory; recurrent fever; interleukin-1; FMF; Familial Mediterranean fever; IL; Interleukin; PFAPA; Periodic fever, aphthous stomatitis, pharyngitis, adenitis;
Keywords: اینترلوکین-1; NSAIDs; Nonsteroidal anti-inflammatory drugs; NF-ĸB; Nuclear Factor-ĸB; COX-2; Cyclooxygenase-2; PGE-2; Prostaglandin E-2; TNF-α; Tumor Necrosis Factor-α; NO; Nitric Oxide; IL-1; Interleukin-1; IL-8; Interleukin-8; LPS; lipopolysaccharide; MAO-A; Mono
Keywords: اینترلوکین-1; Kawasaki disease; Vasculitis; Pediatric; Interleukin-1; Anakinra, coronary artery aneurysms; Pediatrics; Autoinflammatory disease;
Keywords: اینترلوکین-1; Sleep deprivation; Hearing loss; Rat; Cochlea; Interleukin-1; Corticosterone;
Keywords: اینترلوکین-1; α-KG; α-ketoglutarate; c-AMP; cyclic AMP; CREB; c-AMP response element-binding protein; DAB; 1,4-dideoxy-1,4-imino-d-arabinitol; GABA; γ-aminobutyric acid; GPCRs; G protein-coupled receptors; IMM; intermediate medial mesopallium; IL-1; interleukin-1; L
Keywords: اینترلوکین-1; CHAPS; 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate; ALI; air-liquid interface; α-SMA; alpha-smooth muscle actin; ATII; alveolar type II cells; ATS; American Thoracic Society; AFM; atomic force microscopy; COPD; Chronic Obstructive Pulmonary
Keywords: اینترلوکین-1; AP-1; activator protein-1; ATP; adenosine triphosphate; BDNF; brain-derived neurotrophic factor; CCI; chronic constriction injury; CCL2; chemokine C-C motif ligand 2; CCL21; chemokine C-C motif ligand 21; CD11b; cluster of differentiation 11b; CD14; clust
Keywords: اینترلوکین-1; 5-HT; 5-hydroxytryptamine; AA; arachidonic acid; ACh; acetylcholine; ACTH; adrenocorticotrophic hormone; AD; Alzheimer's Disease; ADP; adenosine diphosphate; Aβ; amyloid β; AMP; adenosine monophosphate; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepro
Keywords: اینترلوکین-1; AUC; area under the curve; DAMPs; danger associated molecular patterns; DRG; dorsal root ganglion; HMGB1; high mobility group box 1; IL-1; interleukin-1; MIF; macrophage migration inhibitory factor; Sp5C; trigeminal nucleus caudalis; TLR4; toll-like recep
Keywords: اینترلوکین-1; ALT; alanine amino transferase; AST; aspartate amino transferase; BIX; bixin; CAT; catalase; GPx; glutathione peroxidase; HDL; high density lipoprotein; IL-1; interleukin-1; IL-6; interleukin-6; NBIX; norbixin; NFkB; nuclear factor kappa B; PPAR; peroxiso
Keywords: اینترلوکین-1; TNF-α; tumor necrosis factor-alpha; IL1; interleukin-1; IFN-α; interferon-alpha; FOXP3; forkhead box P3; ROR; RAR-related orphan receptor gamma; Probiotics; Gut microbiota; Cancer immunotherapies; Tumor immunology; Checkpoint inhibitors; PD-1; PDL-1; CT
Keywords: اینترلوکین-1; Interleukin-1; Osteoarthritis; Experimental OA; Animal models; Synovitis; Cartilage destruction;
Keywords: اینترلوکین-1; Concussion; Post-concussion symptoms; Lateral fluid percussion; Glial activation; Interleukin-1; TNF-α; GFAP; IBA-1; Pons; ASR;
Keywords: اینترلوکین-1; Baicalin; Baicalein; Flavonoids; Chemoprevention; Inflammatory diseases; 6-OHDA; 6-hydroxydopamine; 12-LOX; 12-lipoxygenase; AIDS; acquired immunodeficiency disorder syndrome; AhR; aryl hydrocarbon receptor; AIH; autoimmune hepatitis; AICAR; 5-aminoimidaz
Keywords: اینترلوکین-1; ACR; American College of Rheumatology; CAD; coronary artery disease; CKD; chronic kidney disease; CVD; cardiovascular disease; DECT; dual-energy computed tomography; EULAR; European League Against Rheumatism; GFR; glomerular filtration rate; IL-1; interle
Keywords: اینترلوکین-1; Short-term high-fat diet; Amygdala; Hippocampus; Interleukin-1; Voluntary exercise; Interleukin-1 receptor antagonist; Contextual fear conditioning; Microglial priming;
Keywords: اینترلوکین-1; Bone loss; Inflammation; Methoxsalen; Osteoporosis; Ovariectomy-induced; ALP&Alp; alkaline phosphatase; BALP; bone-ALP; BMD; bone mineral density; BS; bone surface; BS/TV; bone surface density; BV; bone volume; BV/TV; bone volume density; Ca; calcium; CPC
Keywords: اینترلوکین-1; cervical fluid; cervical incompetence; cervical stitch; cervicovaginal fluid; cervix; chemokines; cytokines; inflammatory; interferon gamma; interleukin-1; interleukin-6; interleukin-8; interleukin-12; McDonald's cerclage; monocyte chemoattractant prote
Keywords: اینترلوکین-1; T2DM; type 2 diabetes; DPN; diabetic peripheral neuropathy; NLR; neutrophil-to-lymphocyte ratio; VPT; vibration perception threshold; NCV; nerve conduction velocity; EMG; electromyogram; WBC; white blood cell counts; TSH; thyroid stimulating hormone; BMI;
Keywords: اینترلوکین-1; Obesity; Osteoporosis; Bone marrow fat; Inflammation; Fracture; 25OHD; 25-hydroxyvitamin D; 2-AG; 2-arachidonoylglycerol; AEA; N-arachidonoylethanolamine; BAT; brown adipose tissue; BMD; bone mineral density; BMAT; bone marrow adipose tissue; BMI; body ma
Keywords: اینترلوکین-1; Interleukin-1; Single-nucleotide polymorphism; Juvenile idiopathic arthritis;
Keywords: اینترلوکین-1; Interleukin-1; Interleukin-15; Interleukin-17; Monocyte chemotactic protein-1; Endothelial dysfunction; Osteoarthritis;
Keywords: اینترلوکین-1; NLRP3 inflammasome; Age-related macular degeneration; Oxidative damage; Interleukin-1; C5a;
Keywords: اینترلوکین-1; AMPA; alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; ANOVA; analysis of variance; EEG; electroencephalogram; DZP; diazepam; GABA; gamma-aminobutyric acid; IL-1β; interleukin-1 beta; IL-1R1; interleukin-1 receptor type 1; IL-1RA; interleukin-1
Keywords: اینترلوکین-1; Inflammation; Interleukin-1; Peripheral blood mononuclear cells; Monocytes; Lymphocytes; NF-ÎB; Inflammatory signaling;
Keywords: اینترلوکین-1; Glymphatics; Homeostasis; Immune; Interleukin-1; Local sleep; Metabolism; Performance; Plasticity; Synapse; Tumor necrosis factor;
Keywords: اینترلوکین-1; Stroke; Co-morbidity; Systemic inflammation; Middle cerebral artery occlusion; Spectroscopy; Optical imaging; Reperfusion; Interleukin-1; Interleukin-1β;
Keywords: اینترلوکین-1; Chemokine; Atypical chemokine receptor; Regulation of inflammation; Interleukin-1; Innate immunity;
Keywords: اینترلوکین-1; Prokineticin2; Psoriasis; Interleukin-1; Angiogenesis; Inflammation; Cell proliferation;
Keywords: اینترلوکین-1; AMPK; adenosine monophosphate-activated protein kinase; ASD; autism spectrum disorder; BBB; blood-brain barrier; CVD; cardiovascular disease; CDI; Clostridium difficile infection; CD; Crohn's disease; DSS; dextran sulphate sodium; eCB; endocannabinoid; Fi
Keywords: اینترلوکین-1; Multicentric reticulohistyocytosis; Anakinra; Interleukin-1; Non-Langerhans histiocytosis; Destructive polyarthritis
Keywords: اینترلوکین-1; CSF; cerebrospinal fluid; IL-1; interleukin-1; IL-6; interleukin-6; NMDA; N-methyl-d-aspartate; TNF-α; tumor necrosis factor alpha; Ketamine; NMDA receptor; Immune system; Depression;
Keywords: اینترلوکین-1; 18s rRNA; 18S ribosomal RNA; Actin b; beta-actin; BMI; body mass index; CD11b; cluster of differentiation 11b; EPM; elevated plus maze; GAPDH; glyceraldehyde 3-phosphate dehydrogenase; GR; glucocorticoid receptor; HFD; high fat diet; IL-1ra; interleukin-1
Keywords: اینترلوکین-1; Multiple sclerosis; Interleukin-1; Genetic susceptibility; Haplotype;
Keywords: اینترلوکین-1; TNF-α; tumor necrosis factor-α; IL-1; interleukin-1; IL-10; interleukin-10; TGF-β; transforming growth factor-β; Acute-phase reaction; Agent-based model; Infection; Physiological stress; Innate immunity;
Keywords: اینترلوکین-1; IL-1; Interleukin-1; (IL-6); interleukin-6; (TNF-α); tumor necrosis factor-α; UC; ulcerative colitis; RT; reverse transcriptase; ELISA; enzyme-linked immunosorbent assay; ENS; enteric nervous system; CNS; central nervous system; Electro-cautery; Colitis
Keywords: اینترلوکین-1; BMP-7; bone morphogenic protein-7; EMT; epithelial-mesenchymal transition; MAPK; mitogen-activated protein kinase; TGF-β; transforming growth factor beta; ECM; extracellular matrix; HGF; hepatocyte growth factor; P-p38; phosphorylation-p38; AM; alveola
Keywords: اینترلوکین-1; ALT; alanine aminotransferase; CM; cow milk; CPT; carnitine-palmitoyl-transferase; DM; donkey milk; FFA; free fatty acid; GSH; glutathione; GSSG; glutathione disulfide; GST; glutathione-S-transferase; HM; human milk; HOMA; homeostasis model assessment; IL
Keywords: اینترلوکین-1; ANOVA; analysis of variance; Con; Control; con-Mino; control-minocycline; con-Nacl; control-Nacl; EEG; electroencephalographic; ELISA; enzyme-linked immunosorbent assay; GABA; γ-aminobutyric acid; GFAP; glial fibrillary acidic protein; Iba1; ionized calc
Keywords: اینترلوکین-1; Cytokine; Chemokine receptors; Intervertebral disc degeneration; Interleukin-1; IVD; intervertebral disc; ECM; extracellular matrix; MMP; matrix metalloproteinase; ADAMTS; a disintegrin and metalloproteinase with thrombospondin motif; IL-; interleukin-; T
Keywords: اینترلوکین-1; AAV; adeno-associated virus; BMPs; bone morphogenetic proteins; BSA; bovine serum albumin; β-TCP; β-tricalcium phosphate; CaP; calcium phosphate; DBM; demineralized bone matrix; DCM; dichloromethane; ECM; extracellular matrix; FBGCs; foreign body giant
Keywords: اینترلوکین-1; amniocyte; amnion; chemokine (C-C motif) ligand 2; choriodecidua; cytokines; interleukin-1; interleukin-8; Macaca nemestrina; monocyte chemotactic protein 1; myometrium; pregnancy; preterm labor; prostaglandin E2; prostaglandin F2α; tumor necrosis factor
Keywords: اینترلوکین-1; Atopic dermatitis; Cytokine; Interleukin-1; Single nucleotide polymorphisms